bf/NASDAQ:AZTA_icon.jpeg

COM:AZENTA

Azenta Life Sciences

  • Stock

USD

Last Close

45.53

22/11 21:00

Market Cap

2.72B

Beta: -

Volume Today

4.91M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '14
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
Sep '23
Sep '24
average inventory
95.64M
-
97.09M
1.52%
96.60M
0.51%
99.48M
2.99%
101.69M
2.22%
98.22M
3.42%
107.14M
9.09%
87.62M
18.22%
72.97M
16.71%
106.87M
46.46%
121.73M
13.90%
average payables
34.57M
-
39.31M
13.74%
43.01M
9.40%
45.11M
4.89%
52.49M
16.34%
57.66M
9.85%
60.60M
5.10%
52.06M
14.09%
40.51M
22.19%
37.23M
8.10%
40.11M
7.76%
average receivables
78.79M
-
83.28M
5.69%
96.41M
15.77%
113.60M
17.83%
123.39M
8.61%
146.30M
18.57%
177.47M
21.31%
154.08M
13.18%
141.82M
7.96%
160.15M
12.92%
164.62M
2.79%
book value per share
9.65
-
9.38
2.80%
8.08
13.80%
8.73
8.06%
10.18
16.60%
15.83
55.40%
16.50
4.26%
17.85
8.22%
44.91
151.51%
38.25
14.81%
33.27
13.04%
capex per share
-0.08
-
-0.24
189.29%
-0.19
21.70%
-0.19
1.01%
-0.18
2.29%
-0.33
82.71%
-0.54
63.76%
-0.71
31.07%
-1.03
45.34%
-0.60
42.43%
0.70
218.14%
capex to depreciation
-0.24
-
-0.64
172.82%
-0.46
28.61%
-0.46
0.17%
-0.34
25.55%
-0.44
28.26%
-0.61
39.11%
-0.81
32.59%
-1.44
78.40%
-0.46
68.04%
0.41
189.43%
capex to operating cash flow
-0.10
-
-0.37
259.88%
-0.32
12.02%
-0.13
58.68%
-0.17
28.79%
-0.26
51.84%
-1.05
301.65%
-0.35
66.58%
0.17
147.15%
-2.25
1,457.05%
0.74
132.98%
capex to revenue
-0.01
-
-0.03
155.62%
-0.02
21.51%
-0.02
18.70%
-0.02
8.61%
-0.03
50.73%
-0.04
45.80%
-0.10
131.02%
-0.14
35.61%
-0.06
57.46%
0.06
196.08%
cash per share
2.43
-
2.24
8.14%
1.24
44.43%
1.46
17.58%
3.46
136.92%
4.66
34.74%
4.02
13.80%
3.06
23.76%
20.96
583.95%
15.36
26.72%
8.69
43.43%
days of inventory on hand
108.24
-
101.01
6.69%
93.28
7.65%
91.27
2.15%
91.83
0.62%
78.04
15.02%
81.03
3.83%
81.68
0.80%
104.11
27.46%
116.42
11.82%
107.06
8.04%
days payables outstanding
39.03
-
45.06
15.45%
41.44
8.04%
42.12
1.64%
52.90
25.60%
46.64
11.83%
43.58
6.57%
57.29
31.45%
47.04
17.88%
32.51
30.90%
41.27
26.96%
days sales outstanding
60.55
-
57.09
5.72%
69.29
21.38%
63.65
8.14%
72.79
14.35%
77.80
6.89%
76.59
1.55%
85.18
11.20%
107.60
26.33%
85.91
20.16%
96.05
11.80%
debt to assets
0.01
-
0.01
24.57%
0.01
36.90%
0.01
35.22%
0.18
1,101.25%
0.03
81.16%
0.05
56.52%
0.13
152.92%
0.01
90.07%
0.02
58.10%
0.03
33.67%
debt to equity
0.01
-
0.01
25.09%
0.01
41.11%
0.02
37.72%
0.27
1,353.74%
0.04
83.56%
0.07
51.01%
0.18
170.28%
0.01
92.01%
0.02
62.92%
0.03
39.38%
dividend yield
0.03
-
0.03
4.71%
0.03
13.73%
0.01
55.17%
0.01
11.97%
0.01
6.89%
0.01
19.98%
0.00
54.89%
0.00
40.33%
earnings yield
0.04
-
0.02
59.76%
-0.07
513.62%
0.03
139.78%
0.05
61.86%
0.00
92.27%
0.02
413.74%
-0.00
119.94%
-0.00
7.48%
-0.00
21.95%
-0.06
1,386.54%
enterprise value
614.65M
-
708.66M
15.29%
847.29M
19.56%
2.01B
137.31%
2.43B
20.76%
2.42B
0.53%
3.19B
32.04%
7.46B
134.05%
2.60B
65.16%
2.71B
4.06%
2.32B
14.15%
enterprise value over ebitda
21.75
-
14.74
32.25%
19.17
30.08%
20.70
7.95%
35.64
72.21%
23.48
34.12%
22.03
6.17%
397.35
1,703.74%
52.34
86.83%
65.73
25.60%
-14.15
121.53%
ev to operating cash flow
11.43
-
16.21
41.80%
21.42
32.20%
20.90
2.47%
32.83
57.11%
26.57
19.06%
84.23
216.98%
49.81
40.86%
-5.58
111.20%
154.76
2,872.95%
46.21
70.14%
ev to sales
1.27
-
1.28
0.72%
1.51
17.94%
2.90
91.90%
3.84
32.49%
3.09
19.65%
3.55
15.06%
14.53
308.81%
4.68
67.78%
4.07
13.08%
3.54
13.01%
free cash flow per share
0.72
-
0.41
43.50%
0.39
4.75%
1.20
207.23%
0.87
27.52%
0.93
7.29%
-0.03
103.00%
1.31
4,773.15%
-7.26
654.99%
-0.33
95.44%
0.24
173.22%
free cash flow yield
0.07
-
0.03
49.29%
0.03
18.04%
0.04
37.73%
0.03
36.16%
0.03
0.13%
-0.00
102.41%
0.01
2,212.16%
-0.17
1,425.33%
-0.01
96.10%
0.01
175.87%
graham net net
2.01
-
2.05
2.06%
1.15
43.80%
1.24
7.83%
0.12
90.00%
1.84
1,382.81%
2.02
9.76%
-1.97
197.58%
18.46
1,035.13%
12.80
30.67%
5.98
53.25%
graham number
10.11
-
6.67
33.99%
13.58
103.57%
13.30
2.08%
19.47
46.38%
6.99
64.07%
18.09
158.67%
12.50
30.91%
12.34
1.28%
13.61
10.30%
48.07
253.22%
income quality
1.71
-
3.07
80.22%
-0.57
118.51%
1.54
369.99%
0.64
58.68%
0.21
67.30%
0.58
181.19%
1.35
131.75%
-0.22
116.15%
-1.23
461.43%
-0.31
75.03%
intangibles to total assets
0.22
-
0.23
7.15%
0.41
77.84%
0.41
0.08%
0.32
21.52%
0.49
50.20%
0.46
5.32%
0.36
21.93%
0.19
48.34%
0.37
100.72%
0.45
19.68%
interest coverage
-13.36
-
42.76
420.02%
26.99
36.87%
157.14
482.14%
3.30
97.90%
2.09
36.61%
26.65
1,174.24%
-22.85
185.74%
-0.87
96.18%
interest debt per share
0.13
-
0.10
24.33%
0.11
16.63%
0.17
51.00%
2.92
1,616.07%
1.02
65.05%
1.16
13.63%
3.30
184.75%
0.72
78.22%
0.91
26.95%
1.11
21.21%
inventory turnover
3.37
-
3.61
7.17%
3.91
8.29%
4.00
2.20%
3.97
0.61%
4.68
17.67%
4.50
3.69%
4.47
0.79%
3.51
21.54%
3.14
10.57%
3.41
8.74%
invested capital
0.01
-
0.01
25.09%
0.01
41.11%
0.02
37.72%
0.27
1,353.74%
0.04
83.56%
0.07
51.01%
0.18
170.28%
0.01
92.01%
0.02
62.92%
1.83B
7,691,454,312,726.79%
market cap
700.47M
-
789.38M
12.69%
932.38M
18.12%
2.11B
126.55%
2.43B
15.03%
2.67B
9.72%
3.40B
27.64%
7.60B
123.27%
3.21B
57.75%
3.33B
3.59%
2.58B
22.54%
net current asset value
239.16M
-
245.87M
2.80%
167.12M
32.03%
193.03M
15.50%
186.63M
3.31%
270.44M
44.90%
303.94M
12.39%
283.19M
6.83%
2.11B
643.89%
1.07B
49.31%
501.73M
53.01%
net debt to ebitda
-3.04
-
-1.68
44.73%
-1.93
14.68%
-1.05
45.67%
-0.02
97.70%
-2.43
10,033.73%
-1.47
39.47%
-7.06
379.14%
-12.25
73.54%
-15.02
22.56%
1.54
110.23%
net income per share
0.47
-
0.21
55.17%
-1.01
580.73%
0.90
188.74%
1.65
83.77%
0.14
91.69%
0.88
541.79%
-0.39
144.11%
-0.15
61.25%
-0.22
42.81%
-3.09
1,334.71%
operating cash flow per share
0.81
-
0.65
19.61%
0.58
11.01%
1.38
139.58%
1.05
24.13%
1.26
20.33%
0.51
59.23%
2.02
292.17%
-6.22
408.22%
0.26
104.24%
0.95
258.25%
payables turnover
9.35
-
8.10
13.38%
8.81
8.74%
8.67
1.61%
6.90
20.38%
7.83
13.42%
8.38
7.03%
6.37
23.93%
7.76
21.78%
11.23
44.72%
8.84
21.24%
receivables turnover
6.03
-
6.39
6.07%
5.27
17.61%
5.73
8.86%
5.01
12.55%
4.69
6.45%
4.77
1.57%
4.29
10.07%
3.39
20.84%
4.25
25.25%
3.80
10.56%
research and ddevelopement to revenue
0.11
-
0.09
13.33%
0.09
2.66%
0.07
26.25%
0.07
9.55%
0.07
2.99%
0.07
8.70%
0.04
33.72%
0.05
13.64%
0.05
2.98%
0.05
0.05%
return on tangible assets
0.05
-
0.02
52.62%
-0.17
808.40%
0.14
180.59%
0.16
13.06%
0.01
91.92%
0.08
507.32%
-0.02
132.11%
-0.00
84.96%
-0.01
111.40%
-0.14
1,692.92%
revenue per share
7.24
-
8.20
13.17%
8.18
0.24%
9.96
21.76%
8.96
10.03%
10.86
21.21%
12.20
12.32%
6.92
43.27%
7.42
7.17%
10.04
35.35%
12.34
22.96%
roe
0.05
-
0.02
53.88%
-0.13
657.68%
0.10
182.12%
0.16
57.61%
0.01
94.65%
0.05
515.58%
-0.02
140.76%
-0.00
84.60%
-0.01
67.64%
-0.09
1,549.83%
roic
0.00
-
0.02
3,005.66%
-0.14
742.11%
0.08
161.45%
0.11
34.84%
0.04
65.80%
0.05
31.79%
-0.02
133.18%
-0.00
92.28%
-0.01
787.59%
-0.09
655.95%
sales general and administrative to revenue
shareholders equity per share
9.65
-
9.38
2.80%
8.08
13.80%
8.73
8.06%
10.18
16.60%
15.83
55.40%
16.50
4.26%
17.85
8.22%
44.91
151.51%
38.25
14.81%
33.27
13.04%
stock based compensation to revenue
0.02
-
0.02
2.66%
0.02
4.78%
0.02
19.05%
0.03
25.86%
0.03
18.04%
0.02
29.31%
0.05
193.91%
0.02
64.08%
0.01
26.58%
0.02
56.36%
tangible asset value
473.84M
-
455.19M
3.94%
269.71M
40.75%
290.49M
7.70%
362M
24.62%
399.52M
10.36%
493.75M
23.59%
669.44M
35.58%
2.67B
299.04%
1.46B
45.50%
829.53M
43.02%
tangible book value per share
7.11
-
6.75
5.02%
3.94
41.70%
4.18
6.05%
5.14
23.00%
5.55
8.06%
6.71
20.96%
9.02
34.36%
35.67
295.48%
21.97
38.39%
15.60
29.01%
working capital
260.47M
-
259.23M
0.48%
179.54M
30.74%
205.23M
14.31%
399.44M
94.63%
375.21M
6.07%
438.33M
16.82%
432.28M
1.38%
2.23B
415.59%
1.21B
45.80%
627.97M
48.02%

All numbers in USD (except ratios and percentages)